Literature DB >> 19815553

Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen.

Robin J Marjoram1, Bryan Voss, Yumei Pan, S Kent Dickeson, Mary M Zutter, Heidi E Hamm, Samuel A Santoro.   

Abstract

Thrombin and fibrillar collagen are potent activators of platelets at sites of vascular injury. Both agonists cause platelet shape change, granule secretion, and aggregation to form the primary hemostatic plug. Human platelets express two thrombin receptors, protease-activated receptors 1 and 4 (PAR1 and PAR4) and two collagen receptors, the alpha(2)beta(1) integrin (alpha(2)beta(1)) and the glycoprotein VI (GPVI)/FcRgamma chain complex. Although these receptors and their signaling mechanisms have been intensely studied, it is not known whether and how these receptors cooperate in the hemostatic function of platelets. This study examined cooperation between the thrombin and collagen receptors in platelet adhesion by utilizing a collagen-related peptide (alpha2-CRP) containing the alpha(2)beta(1)-specific binding motif, GFOGER, in conjunction with PAR-activating peptides. We demonstrate that platelet adhesion to alpha2-CRP is substantially enhanced by suboptimal PAR activation (agonist concentrations that do not stimulate platelet aggregation) using the PAR4 agonist peptide and thrombin. The enhanced adhesion induced by suboptimal PAR4 activation was alpha(2)beta(1)-dependent and GPVI/FcRgamma-independent as revealed in experiments with alpha(2)beta(1)- or FcRgamma-deficient mouse platelets. We further show that suboptimal activation of other platelet G(q)-linked G protein-coupled receptors (GPCRs) produces enhanced platelet adhesion to alpha2-CRP. The enhanced alpha(2)beta(1)-mediated platelet adhesion is controlled by phospholipase C (PLC), but is not dependent on granule secretion, activation of alpha(IIb)beta(3) integrin, or on phosphoinositol-3 kinase (PI3K) activity. In conclusion, we demonstrate a platelet priming mechanism initiated by suboptimal activation of PAR4 or other platelet G(q)-linked GPCRs through a PLC-dependent signaling cascade that promotes enhanced alpha(2)beta(1) binding to collagens containing GFOGER sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815553      PMCID: PMC2787326          DOI: 10.1074/jbc.M109.020990

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors.

Authors:  J M Clemetson; J Polgar; E Magnenat; T N Wells; K J Clemetson
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

2.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

Authors:  M L Kahn; M Nakanishi-Matsui; M J Shapiro; H Ishihara; S R Coughlin
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens.

Authors:  Pia R-M Siljander; Samir Hamaia; Anthony R Peachey; David A Slatter; Peter A Smethurst; Willem H Ouwehand; C Graham Knight; Richard W Farndale
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

4.  Platelets interact with soluble and insoluble collagens through characteristically different reactions.

Authors:  S M Jung; M Moroi
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

5.  A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets.

Authors:  M Tsuji; Y Ezumi; M Arai; H Takayama
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

6.  GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow.

Authors:  Kendra L Sarratt; Hong Chen; Mary M Zutter; Samuel A Santoro; Daniel A Hammer; Mark L Kahn
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

7.  A dual thrombin receptor system for platelet activation.

Authors:  M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

8.  Adhesion of human and mouse platelets to collagen under shear: a unifying model.

Authors:  Jocelyn M Auger; Marijke J E Kuijpers; Yotis A Senis; Steve P Watson; Johan W M Heemskerk
Journal:  FASEB J       Date:  2005-03-09       Impact factor: 5.191

9.  The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion.

Authors:  Kazunobu Kato; Taisuke Kanaji; Susan Russell; Thomas J Kunicki; Kenichi Furihata; Sachiko Kanaji; Patrizia Marchese; Armin Reininger; Zaverio M Ruggeri; Jerry Ware
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

10.  Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

Authors:  B Savage; F Almus-Jacobs; Z M Ruggeri
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

View more
  4 in total

1.  Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.

Authors:  Trenis D Palmer; Carlos H Martínez; Catalina Vasquez; Katie E Hebron; Celestial Jones-Paris; Shanna A Arnold; Susanne M Chan; Venu Chalasani; Jose A Gomez-Lemus; Andrew K Williams; Joseph L Chin; Giovanna A Giannico; Tatiana Ketova; John D Lewis; Andries Zijlstra
Journal:  Cancer Res       Date:  2013-11-12       Impact factor: 12.701

2.  α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis.

Authors:  Robin J Marjoram; Zhengzhi Li; Li He; Douglas M Tollefsen; Thomas J Kunicki; S Kent Dickeson; Samuel A Santoro; Mary M Zutter
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

3.  Quantification of Cardiovascular Disease Biomarkers in Human Platelets by Targeted Mass Spectrometry.

Authors:  Sebastian Malchow; Christina Loosse; Albert Sickmann; Christin Lorenz
Journal:  Proteomes       Date:  2017-11-15

4.  Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.

Authors:  Patricia P Wadowski; Beate Eichelberger; Christoph W Kopp; Joseph Pultar; Daniela Seidinger; Renate Koppensteiner; Irene M Lang; Simon Panzer; Thomas Gremmel
Journal:  J Cardiovasc Transl Res       Date:  2017-04-19       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.